News
COVID-19: Cancer World editor and immunologist Adriana Albini explains how it works and how researchers are hoping to tame it
International collaboration, data sharing and investing in research is how we’ll tame the COVID-19 virus, explains Cancer World editor Adriana Albini. An immunologist now on the Board of Directors of the American Association of Cancer Research, Albini was part of…
Parity and breast cancer risk are not so strictly linked
The reduction in birth rate has been blamed in the past for the increase in breast cancer in young women, but now a study just published in JAMA Network Open (JAMA Netw Open. 2020;3(3):e200929. doi:10.1001/jamanetworkopen.2020.0929) offers evidence refuting this hypothesis:…
Cancer survivors need more (and longer) support
After defeating cancer, people are facing other worries, which too often remain unsolved, even though they are seeking for help, according to a Canadian study concluding that it’s time to enhance survivorship care: «Without appropriate support systems in place, these…
COVID-19: ECCO demands attention to protect cancer patients
The COVID-19 pandemic poses a significant threat for cancer patients, which deserve to be protected through immediate action on several levels all over Europe, according to a statement published today by the European Cancer Organisation (ECCO). Matti Aapro, President of…
Can we still rely on Omega-3 & Co. for cancer prevention and management?
According to an extensive systematic review recently published in the British Journal of Cancer, there is no evidence for a protective role of polyunsaturated fat (PUFAs) against the risk of cancer. Moreover, a very high intake of total PUFAs could…
COVID-19 and cancer, still more questions than answers
COVID-19 outbreak poses a severe threat to the health of millions of people worldwide, including cancer patients. What do we know about SARS-CoV-2 infection in this specific population? The analysis of data coming from a prospective cohort established by the…
More evidence-based info on off-patent oncology drugs
The American Association for Cancer Research (AACR) has offered help to the U.S. Food and Drug Administration (FDA) on its ambitious Project Renewal, that aims to evaluate accumulated scientific evidence on safety and efficacy of long-standing off-patent oncology drugs, so…
A step forward in prostate cancer screening optimisation
A single prostate-specific antigen (PSA) measurement in midlife may help to personalise prostate cancer screening, resulting in a reduced risk of overdiagnosis and overtreatment of indolent cancers. The authors of the study just published in JAMA Network Open came to this…
UNESCO pledges to end the gender imbalance in science
[caption id="attachment_9614" align="alignright" width="476"] One of the images with quotes prepared by UNESCO for the International day of Women and Girls in Science 2020[/caption] Science and gender equality are both vital for the achievement of the internationally agreed development goals,…
New evidence shows effectiveness of a single-dose of HPV vaccine
To prevent pre-invasive cervical disease, a single dose of the human papillomavirus (HPV) vaccine could be enough. Investigation of more than 130,000 young women suggests that 1 dose of quadrivalent (4vHPV) vaccine has the same effectiveness of 2 doses, recommended…